About Us

DM Intelligence

DM Intelligence is an artificial intelligence development company that built AI solutions for small molecule drugs with high specific and affinity. Our proprietary platform, Artificial Intelligence Drug Discovery Platform (AI-DDP), integrates artificial intelligence technologies into the medical field to provide better service to pharmaceutical companies, academic centers and biotech companies.

AI-DDP allow us to optimize leads with specific desired properties as well as design small molecules targeting specific site or receptor. Our platform has extensive capabilities of analyzing and predicting physicochemical properties, biological and toxicological activities of candidate drugs based on their structures. With all these techniques, we strive for break thoughts in the future of drug discovery and research.



Hit Identification

Predictive Models

Founder/CEO WeiDong Xie

PhD. Imperial College London.

Professor, Sun Yat-sen University

Director, St. Jude Children's Research Hospital

CTO, CK Life Science Group

CEO Lindan Biotech, Canada.

VP Biotherapy Inc
Dr. RiQiang Deng

Professor, Sun Yat-sen University

Bioinformatics scientist IT, and AI, deep learning, neural network.
Dr. Da-Wei Gu

PhD. Imperial College London

Professor in Engineering, University of Leicester

Research interests include robust control, optimal control, optimization algorithms.

Chartered Engineer

a Fellow of IET
Dr.PingHua Sun

At present, he is the head of Department of pharmacy, School of pharmacy, Jinan University

Master of pharmaceutical chemistry, Shenyang Pharmaceutical University
Doctor of Biomedical Engineering, Jinan University
University of South Florida School of Medicine / Moffitt Cancer Institute postdoctoral

College of pharmacy,Jinan University:Assistant(2002-2004)
College of pharmacy,Jinan University:lecturer(2004-2010)
College of pharmacy,Jinan University:associate professor/Master Tutor(2010-2015)
College of pharmacy,Jinan University:professor/Doctoral supervisor(2015-Now)


client client client client client client client client


DM Intelligence Raises Approximately ¥10 Million CNY ($1.5M USD) in Angel Round for Advance AI + Drug Discovery

April 19, 2021
Know More

DM intelligence to attend 2021 AACR annual meeting

April 13, 2021
Know More

Win win cooperation to promote the research and development of artificial intelligence innovative drugs
DEC 19, 2020
Know More


WeiDong Xie


RiQiang Deng


DaWei Gu


PingHua Sun


Contact Us